Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy

JP. Kaski, JAE. Kammeraad, NA. Blom, JM. Happonen, J. Janousek, S. Klaassen, G. Limongelli, I. Östman-Smith, G. Sarquella Brugada, L. Ziolkowska

. 2023 ; 33 (5) : 681-698. [pub] 20230427

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011528
E-zdroje Online Plný text

NLK ProQuest Central od 2001-03-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2001-03-01 do Před 1 rokem

Odkazy

PubMed 37102324
DOI 10.1017/s1047951123000872
Knihovny.cz E-zdroje

Sudden cardiac death is the most common mode of death during childhood and adolescence in hypertrophic cardiomyopathy, and identifying those individuals at highest risk is a major aspect of clinical care. The mainstay of preventative therapy is the implantable cardioverter-defibrillator, which has been shown to be effective at terminating malignant ventricular arrhythmias in children with hypertrophic cardiomyopathy but can be associated with substantial morbidity. Accurate identification of those children at highest risk who would benefit most from implantable cardioverter-defibrillator implantation while minimising the risk of complications is, therefore, essential. This position statement, on behalf of the Association for European Paediatric and Congenital Cardiology (AEPC), reviews the currently available data on established and proposed risk factors for sudden cardiac death in childhood-onset hypertrophic cardiomyopathy and current approaches for risk stratification in this population. It also provides guidance on identification of individuals at risk of sudden cardiac death and optimal management of implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011528
003      
CZ-PrNML
005      
20230801133120.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1017/S1047951123000872 $2 doi
035    __
$a (PubMed)37102324
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kaski, Juan Pablo $u Centre for Paediatric Inherited and Rare Cardiovascular Disease, University College London Institute of Cardiovascular Science, London, UK $u Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital, London, UK $1 https://orcid.org/0000000200149927
245    10
$a Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy / $c JP. Kaski, JAE. Kammeraad, NA. Blom, JM. Happonen, J. Janousek, S. Klaassen, G. Limongelli, I. Östman-Smith, G. Sarquella Brugada, L. Ziolkowska
520    9_
$a Sudden cardiac death is the most common mode of death during childhood and adolescence in hypertrophic cardiomyopathy, and identifying those individuals at highest risk is a major aspect of clinical care. The mainstay of preventative therapy is the implantable cardioverter-defibrillator, which has been shown to be effective at terminating malignant ventricular arrhythmias in children with hypertrophic cardiomyopathy but can be associated with substantial morbidity. Accurate identification of those children at highest risk who would benefit most from implantable cardioverter-defibrillator implantation while minimising the risk of complications is, therefore, essential. This position statement, on behalf of the Association for European Paediatric and Congenital Cardiology (AEPC), reviews the currently available data on established and proposed risk factors for sudden cardiac death in childhood-onset hypertrophic cardiomyopathy and current approaches for risk stratification in this population. It also provides guidance on identification of individuals at risk of sudden cardiac death and optimal management of implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
650    _2
$a mladiství $7 D000293
650    _2
$a lidé $7 D006801
650    _2
$a dítě $7 D002648
650    12
$a defibrilátory implantabilní $7 D017147
650    _2
$a rizikové faktory $7 D012307
650    _2
$a srdeční arytmie $x etiologie $7 D001145
650    _2
$a náhlá srdeční smrt $x etiologie $7 D016757
650    12
$a hypertrofická kardiomyopatie $x terapie $7 D002312
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Kammeraad, Janneke A E $u Erasmus MC - Sophia Children's Hospital, Department of Paediatric Cardiology, Rotterdam, the Netherlands
700    1_
$a Blom, Nico A $u Department of Pediatric Cardiology, University of Leiden, Leiden, the Netherlands $u Amsterdam University Medical Centre, Amsterdam, the Netherlands
700    1_
$a Happonen, Juha-Matti $u Department of Paediatric Cardiology, Helsinki University Children's Hospital, Helsinki, Finland
700    1_
$a Janousek, Jan $u Children's Heart Center, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000249321150 $7 jo2003180379
700    1_
$a Klaassen, Sabine $u Department of Pediatric Cardiology, Charite-Universitatsmedizin Berlin, Berlin, Germany
700    1_
$a Limongelli, Giuseppe $u Inherited and Rare Cardiovascular Disease Unit, AO dei Colli Monaldi Hospital, Universita della Campania "Luigi Vanvitelli", Naples, Italy $1 https://orcid.org/0000000282919517
700    1_
$a Östman-Smith, Ingegerd $u Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
700    1_
$a Sarquella Brugada, Georgia $u Hospital Sant Joan de Deu, Barcelona, Spain
700    1_
$a Ziolkowska, Lidia $u The Children's Memorial Health Institute, Warsaw, Poland
773    0_
$w MED00008807 $t Cardiology in the young $x 1467-1107 $g Roč. 33, č. 5 (2023), s. 681-698
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37102324 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133116 $b ABA008
999    __
$a ok $b bmc $g 1963757 $s 1197793
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 33 $c 5 $d 681-698 $e 20230427 $i 1467-1107 $m Cardiology in the young $n Cardiol Young $x MED00008807
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Možnosti archivace